Cart
sales@molnova.com
Girisopam
CAS No. 82230-53-3
Girisopam( —— )
Catalog No. M36178 CAS No. 82230-53-3
Girisopam is a novel selective benzodiazepine analog for the 2,3-benzodiazepine binding site, an atypical psychoanalytic with anxiolytic effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 198 | Get Quote |
|
| 5MG | 304 | Get Quote |
|
| 10MG | 456 | Get Quote |
|
| 25MG | 723 | Get Quote |
|
| 50MG | 994 | Get Quote |
|
| 100MG | 1332 | Get Quote |
|
| 500MG | 2664 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGirisopam
-
NoteResearch use only, not for human use.
-
Brief DescriptionGirisopam is a novel selective benzodiazepine analog for the 2,3-benzodiazepine binding site, an atypical psychoanalytic with anxiolytic effects.
-
DescriptionGirisopam is a novel selective benzodiazepine analog for the 2,3-benzodiazepine binding site, an atypical psychoanalytic with anxiolytic effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number82230-53-3
-
Formula Weight328.79
-
Molecular FormulaC18H17ClN2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C)C=1C=C2C(=NN=C(C)CC2=CC1OC)C3=CC(Cl)=CC=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Dipotassium glycyrrh...
Dipotassium glycyrrhizinate is an anionic surfactant having anti-allergic and anti-inflammatory activities.
-
Dehydrocostus Lacton...
Dehydrocostus Lactone is a major sesquiterpene lactone isolated from the roots of Saussurea lappa.
-
Metastin (human)
Potent endogenous ligand of the kisspeptin receptor (KISS1, GPR54). Binds with high affinity to rat and human KISS1 receptors with Ki values of 1.80 and 1.45 nM respectively. Inhibits chemotaxis, invasion and metastasis of human melanomas and breast carcinomas. Stimulates gonadotropin secretion following i.c.v. administration.
